ArticleJournal of ionic liquids2024
Designing dicationic organic salts and ionic liquids exhibiting high fluorescence in the solid state.
Article in Journal of ionic liquids, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dicationic ionic liquids as green functional materials.RSC advances · 2026Review
- Design and synthesis of phosphonium ionic liquids exhibiting strong fluorescence in various solvents and liquid or glassy state.Journal of ionic liquids · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dicationic ionic liquids (DILs) are emerging as a powerful, next-generation approach to designing applied ILs because of their superior physicochemical properties as well as their diverse complexity and tunability for task specific applications. DILs are scarce in the literature compared to monocationic ILs (MILs), and one of their main issues is their expected tendency to possess higher melting temperatures. A series of 1,4-bis[2-(4-pyridyl)ethenyl] benzene and 1,4-bis[2-(2-pyridyl)ethenyl]benzene quaternary salts (Q-BPEBs) with different counterions (bromide, tosylate, and triflimide) and carbon chain lengths (C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.